Efficacy of botulinum toxin in male androgenetic alopecia: A triple-blind, randomized clinical trial
Authors:
- Daniel Fernandes MeloDMDaniel Fernandes Melo
- Paulo Müller-RamosPMPaulo Müller-Ramos
- Rita Fernanda Cortez de AlmeidaRARita Fernanda Cortez de Almeida
- Carla Jorge MachadoCMCarla Jorge Machado
- Sidney FrattiniSFSidney Frattini
- André Luiz Vairo DondaADAndré Luiz Vairo Donda
- Daniela Alves Pereira AnteloDADaniela Alves Pereira Antelo
- Carlos Baptista BarcauiCBCarlos Baptista Barcaui
- 22 July 2024
- journal article
- Published by Elsevier in Journal of the American Academy of Dermatology
- Vol. 91 (5) , 996-998
Abstract
No abstract availableFunding Information
- AbbVie Inc
This publication has 5 references indexed in Scilit:
- Hair-to-Hair Trichoscopy: An Objective Method to Assess Effectiveness of Botulinum Toxin in a Clinical Trial for Androgenetic AlopeciaSkin Appendage Disorders, 2023
- Use of Botulinum Toxin for Androgenic Alopecia: A Systematic ReviewSkin Appendage Disorders, 2021
- Is there a rationale for the use of botulinum toxin in the treatment of Androgenetic Alopecia?Journal of Cosmetic Dermatology, 2021
- Is there a therapeutic effect of botulinum toxin on scalp alopecia? Physiopathology and reported cases: A systematic review of the literatureJournal of Plastic, Reconstructive & Aesthetic Surgery, 2020
- Botulinum toxin as a double‐edged sword in alopecia: A systematic reviewJournal of Cosmetic Dermatology, 2020